Self-support protocol
PMS protocol balancing hormonal and nervous system teams. Ease symptoms through endocrine system harmony.
Premenstrual syndrome involves dramatic hormonal fluctuations affecting neurotransmitters, fluid balance, and even brain structure! The science is fascinating!
Progesterone withdrawal - after ovulation, the corpus luteum produces progesterone, reaching peak levels mid-luteal phase (days 21-23 of a 28-day cycle). If pregnancy doesn't occur, progesterone plummets in the late luteal phase. This sudden withdrawal triggers a cascade of neurochemical changes!
Estrogen fluctuation - estrogen peaks just before ovulation, drops briefly, rises again in the mid-luteal phase, then decreases premenstrually. These fluctuations affect serotonin receptors, GABA receptor sensitivity, and neurosteroid production!
Allopregnanolone dynamics - this neurosteroid metabolite of progesterone acts as a positive allosteric modulator of GABA-A receptors (similar to benzodiazepines). High levels during the luteal phase enhance GABAergic inhibition. Rapid withdrawal creates relative GABA deficiency, contributing to anxiety and irritability!
Serotonin sensitivity - estrogen increases serotonin synthesis (by increasing tryptophan hydroxylase) and decreases serotonin reuptake. Progesterone affects serotonin receptor density and sensitivity. The premenstrual decline in these hormones creates relative serotonin deficiency! SSRIs taken only during the luteal phase effectively treat PMDD (premenstrual dysphoric disorder)!
GABA receptor changes - progesterone metabolites enhance GABA-A receptor function. During progesterone withdrawal, these receptors show reduced sensitivity to GABA, creating CNS hyperexcitability. This explains increased anxiety, irritability, and even seizure susceptibility!
Dopamine modulation - ovarian hormones affect dopamine metabolism. Estrogen enhances dopamine release and receptor sensitivity, while progesterone has opposite effects. Hormonal fluctuations alter the reward system, affecting mood and motivation!
Aldosterone and renin - the renin-angiotensin-aldosterone system shows cyclic variation. Estrogen stimulates hepatic angiotensinogen production. Progesterone has anti-mineralocorticoid effects (competing with aldosterone). The late luteal phase often shows relative aldosterone predominance, causing sodium and water retention!
Vasopressin elevation - antidiuretic hormone levels increase premenstrually, contributing to fluid retention. This increases extracellular fluid volume by 1-2 liters in some women, causing bloating and breast tenderness!
Aquaporin regulation - these water channel proteins in kidneys are regulated by hormones. Altered expression affects water reabsorption and can contribute to cyclic edema!
Uterine prostaglandins - declining progesterone removes inhibition of endometrial prostaglandin synthesis. PGF2α and PGE2 levels increase dramatically. PGF2α causes uterine contractions (dysmenorrhea) and has systemic effects including nausea, diarrhea, and headache!
COX-2 expression - cyclooxygenase-2 enzyme expression increases in the endometrium during the late luteal phase, converting arachidonic acid to prostaglandins. NSAIDs taken prophylactically reduce prostaglandin synthesis and alleviate many PMS symptoms!
Cytokine fluctuations - IL-6, TNF-α, and CRP show cyclic variation, with some studies showing increased pro-inflammatory markers premenstrually. This low-grade inflammation may contribute to mood symptoms, fatigue, and pain sensitivity!
Mast cell activation - estrogen and progesterone affect mast cell degranulation. Some women show increased histamine release premenstrually, potentially contributing to migraines, allergic symptoms, and anxiety!
Hippocampal plasticity - incredibly, the hippocampus shows structural changes across the menstrual cycle! Estrogen increases dendritic spine density in CA1 region, enhancing synaptic connectivity. MRI studies show cyclic volume changes in hippocampus and amygdala!
Amygdala reactivity - fMRI shows increased amygdala activation to negative stimuli during the late luteal phase. Progesterone withdrawal may reduce prefrontal-amygdala connectivity, impairing emotional regulation!
Neurotransmitter receptor cycling - GABA-A receptor subunit expression changes across the cycle. α4β2δ receptors (which show reduced benzodiazepine sensitivity) increase during progesterone withdrawal, contributing to anxiety!
GABA-A receptor genetics - variations in genes encoding GABA-A receptor subunits affect sensitivity to neurosteroid effects. Some polymorphisms predict PMS/PMDD susceptibility!
Serotonin transporter gene - the short allele of 5-HTTLPR (serotonin transporter gene promoter region) is associated with increased PMS/PMDD risk. This allele causes lower serotonin transporter expression and altered serotonin signaling!
Estrogen receptor polymorphisms - variations in ESR1 and ESR2 genes affect estrogen signaling and may influence PMS symptom severity!
What remarkable biology! PMS involves orchestrated hormonal changes affecting neurotransmitter systems, fluid balance, inflammatory processes, and even brain structure. Understanding these mechanisms validates that PMS is a real neuroendocrine phenomenon, not "just emotions"!
Premenstrual syndrome (PMS) involves physical and emotional symptoms in the luteal phase of your menstrual cycle, caused by fluctuating estrogen and progesterone levels affecting neurotransmitter systems. After ovulation, progesterone rises then falls sharply before menstruation. This affects your GABA receptors (reducing calming signals), serotonin production (affecting mood), and inflammatory signaling. Your brain's emotional regulation centers—amygdala, hippocampus, prefrontal cortex—have estrogen and progesterone receptors that modulate their activity. When hormone levels drop, these areas become more reactive: your amygdala responds more strongly to negative stimuli, your prefrontal cortex has less regulatory control, and your hippocampus processes memories more emotionally. Meanwhile, prostaglandins (inflammatory molecules) increase in your uterine tissue, causing cramping, but also affect your brain, contributing to mood changes. Fluid retention from aldosterone changes causes bloating and breast tenderness. The 'organism as team' perspective helps because your endocrine, nervous, and immune systems are all responding to normal cyclical hormone shifts—nothing is broken, but the coordination creates temporary symptoms. Your ovaries are following their program, your uterus is preparing then shedding lining, your brain chemistry is fluctuating with hormones, and your mood reflects these real neurochemical changes. Supporting your team means calcium and magnesium to stabilize neurotransmission, complex carbohydrates to support serotonin, exercise to reduce inflammation, and stress management to prevent amplification of symptoms. Your organism is cycling through natural phases. ⚕️ This protocol does not replace professional consultation.